Pulished Date October, 2018
ID: 593
Share on
Share on

Middle-East And Africa Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 593
Pages: 145

 Middle-East and Africa Companion Diagnostics Market was worth USD 0.11 million in 2018 and estimated to be growing at a CAGR of 21.11%, to reach USD 0.29  million by 2023.

Companion diagnostic has the potential to totally modify the drug development process and commercialization of the drug diagnoses will make drugs with a better therapeutic efficiency in a faster and cost-effective way. Companion diagnostics has been extremely advantageous to identify patients with precise biomarkers that have predictive responses.

Innovative technologies such as next-generation sequencing (NGS), growing acceptance of companion diagnostic kits/tests by the pharmaceutical industry and boost from controlling bodies are anticipated to enhance the market. NGS-based companion diagnostics is one of the major factors that will drive the market due to its ability of identifying multiple genes at a single time. Regulatory uncertainty and cost allied with developing drugs are expected to hamper the market growth of companion diagnostic market.

The Middle-East and Africa clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.

Based on geography the Middle-East and Africa market is analysed under various regions namely, Middle-East and Africa. Africa is expected to grow at highest CAGR in this region for the coming years.

Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Companion Diagnostics Market By Region, From 2018-2023 (USD million)
  2. Middle East & Africa Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  3. Middle East & Africa Oncology Market By Region, From 2018-2023 (USD million)
  4. Middle East & Africa Inflammation and Autoimmune Diseases Market By Region, From 2018-2023 (USD million)
  5. Middle East & Africa Cardiovascular Diseases Market By Region, From 2018-2023 (USD million)
  6. Middle East & Africa Central Nervous System Disorders Market By Region, From 2018-2023 (USD million)
  7. Middle East & Africa Virology Diseases Market By Region, From 2018-2023 (USD million)
  8. Middle East & Africa Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  9. Middle East & Africa Immuno Histochemistry Market By Region, From 2018-2023 (USD million)
  10. Middle East & Africa Molecular Diagnostics Market By Region, From 2018-2023 (USD million)
  11. Middle East & Africa Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  12. Middle East & Africa Colorectal Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  13. Middle East & Africa Breast Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  14. Middle East & Africa Lung Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  15. Middle East & Africa Gastric Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  16. Middle East & Africa Melanoma Diagnostics Market By Region, From 2018-2023 (USD million)
  17. Middle East & Africa Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  18. Middle East & Africa In-Situ Hybridization Market By Region, From 2018-2023 (USD million)
  19. Middle East & Africa Real Time PCR Market By Region, From 2018-2023 (USD million)
  20. Middle East & Africa Gene Sequencing Market By Region, From 2018-2023 (USD million)
  21. Middle East Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  22. Middle East Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  23. Middle East Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  24. Middle East Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  25. Africa Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  26. Africa Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  27. Africa Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  28. Africa Molecular Diagnostics Market By Type, From 2018-2023 (USD million)

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients